Annual total expenses:
$48.69B-$6.45B(-11.69%)Summary
- As of today (June 22, 2025), PFE annual total expenses is $48.69 billion, with the most recent change of -$6.45 billion (-11.69%) on December 31, 2024.
- During the last 3 years, PFE annual total expenses has fallen by -$8.89 billion (-15.45%).
- PFE annual total expenses is now -22.79% below its all-time high of $63.06 billion, reached on December 31, 2022.
Performance
PFE Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$9.29B-$5.29B(-36.27%)Summary
- As of today (June 22, 2025), PFE quarterly total expenses is $9.29 billion, with the most recent change of -$5.29 billion (-36.27%) on March 29, 2025.
- Over the past year, PFE quarterly total expenses has dropped by -$1.39 billion (-12.97%).
- PFE quarterly total expenses is now -51.21% below its all-time high of $19.04 billion, reached on December 31, 2022.
Performance
PFE Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
PFE Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.7% | -13.0% |
| 3 y3 years | -15.4% | -40.9% |
| 5 y5 years | +44.9% | +32.7% |
PFE Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.8% | at low | -51.2% | at low |
| 5 y | 5-year | -22.8% | +48.3% | -51.2% | +32.7% |
| alltime | all time | -22.8% | +1511.7% | -51.2% | +689.6% |
PFE Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $9.29B(-36.3%) |
| Dec 2024 | $48.69B(-11.7%) | $14.58B(+17.4%) |
| Sep 2024 | - | $12.42B(+12.7%) |
| Jun 2024 | - | $11.02B(+3.2%) |
| Mar 2024 | - | $10.68B(-34.2%) |
| Dec 2023 | $55.14B(-12.6%) | $16.22B(-1.3%) |
| Sep 2023 | - | $16.44B(+55.6%) |
| Jun 2023 | - | $10.57B(-11.3%) |
| Mar 2023 | - | $11.91B(-37.4%) |
| Dec 2022 | $63.06B(+9.5%) | $19.04B(+46.8%) |
| Sep 2022 | - | $12.97B(-15.4%) |
| Jun 2022 | - | $15.33B(-2.4%) |
| Mar 2022 | - | $15.71B(-13.9%) |
| Dec 2021 | $57.58B(+75.4%) | $18.24B(+10.7%) |
| Sep 2021 | - | $16.48B(+26.0%) |
| Jun 2021 | - | $13.07B(+33.6%) |
| Mar 2021 | - | $9.79B(-7.3%) |
| Dec 2020 | $32.82B(-2.3%) | $10.56B(+34.9%) |
| Sep 2020 | - | $7.83B(+5.3%) |
| Jun 2020 | - | $7.43B(+6.1%) |
| Mar 2020 | - | $7.00B(+8.3%) |
| Dec 2019 | $33.59B(-1.5%) | $6.47B(-30.9%) |
| Sep 2019 | - | $9.36B(+2.7%) |
| Jun 2019 | - | $9.11B(+5.3%) |
| Mar 2019 | - | $8.66B(+37.8%) |
| Dec 2018 | $34.09B(-11.4%) | $6.29B(-33.5%) |
| Sep 2018 | - | $9.45B(+0.0%) |
| Jun 2018 | - | $9.45B(+6.0%) |
| Mar 2018 | - | $8.91B(-21.2%) |
| Dec 2017 | $38.47B(-1.6%) | $11.31B(+20.5%) |
| Sep 2017 | - | $9.39B(+3.4%) |
| Jun 2017 | - | $9.09B(+4.6%) |
| Mar 2017 | - | $8.69B(-23.1%) |
| Dec 2016 | $39.11B(+9.0%) | $11.29B(+19.0%) |
| Sep 2016 | - | $9.49B(+1.5%) |
| Jun 2016 | - | $9.35B(+4.2%) |
| Mar 2016 | - | $8.97B(-23.9%) |
| Dec 2015 | $35.88B(-0.6%) | $11.79B(+44.6%) |
| Sep 2015 | - | $8.15B(-0.3%) |
| Jun 2015 | - | $8.17B(+5.2%) |
| Mar 2015 | - | $7.77B(-28.4%) |
| Dec 2014 | $36.11B(+2.5%) | $10.84B(+24.6%) |
| Sep 2014 | - | $8.70B(-0.5%) |
| Jun 2014 | - | $8.74B(+11.7%) |
| Mar 2014 | - | $7.83B(-20.8%) |
| Dec 2013 | $35.22B(-6.3%) | $9.88B(+17.3%) |
| Sep 2013 | - | $8.43B(-0.9%) |
| Jun 2013 | - | $8.50B(+1.1%) |
| Mar 2013 | - | $8.41B(-18.6%) |
| Dec 2012 | $37.58B(-15.0%) | $10.33B(+16.1%) |
| Sep 2012 | - | $8.90B(-0.2%) |
| Jun 2012 | - | $8.92B(-12.5%) |
| Mar 2012 | - | $10.20B(+7.1%) |
| Dec 2011 | $44.23B(-9.0%) | $9.52B(-16.7%) |
| Sep 2011 | - | $11.43B(-4.6%) |
| Jun 2011 | - | $11.99B(+2.8%) |
| Mar 2011 | - | $11.66B(+10.0%) |
| Dec 2010 | $48.61B(+41.8%) | $10.60B(-22.9%) |
| Sep 2010 | - | $13.76B(+14.5%) |
| Jun 2010 | - | $12.02B(-1.8%) |
| Mar 2010 | - | $12.24B(-6.0%) |
| Dec 2009 | $34.29B(-6.6%) | $13.02B(+79.3%) |
| Sep 2009 | - | $7.26B(-2.0%) |
| Jun 2009 | - | $7.40B(+13.7%) |
| Mar 2009 | - | $6.51B(-44.4%) |
| Dec 2008 | $36.70B(-3.6%) | $11.72B(+43.8%) |
| Sep 2008 | - | $8.15B(-8.8%) |
| Jun 2008 | - | $8.94B(+11.0%) |
| Mar 2008 | - | $8.05B(-21.8%) |
| Dec 2007 | $38.08B(+11.7%) | $10.29B(-7.8%) |
| Sep 2007 | - | $11.16B(+25.4%) |
| Jun 2007 | - | $8.90B(+15.2%) |
| Mar 2007 | - | $7.73B(-22.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $34.09B(+2.7%) | $10.01B(+18.9%) |
| Sep 2006 | - | $8.41B(+2.1%) |
| Jun 2006 | - | $8.24B(+10.8%) |
| Mar 2006 | - | $7.43B(-18.6%) |
| Dec 2005 | $33.20B(+2.0%) | $9.14B(+18.5%) |
| Sep 2005 | - | $7.71B(-6.1%) |
| Jun 2005 | - | $8.21B(-7.9%) |
| Mar 2005 | - | $8.92B(+22.3%) |
| Dec 2004 | $32.56B(-5.3%) | $7.30B(-13.2%) |
| Sep 2004 | - | $8.41B(-2.9%) |
| Jun 2004 | - | $8.66B(+5.6%) |
| Mar 2004 | - | $8.20B(-27.4%) |
| Dec 2003 | $34.37B(+71.2%) | $11.30B(+15.8%) |
| Sep 2003 | - | $9.76B(+21.5%) |
| Jun 2003 | - | $8.03B(+59.7%) |
| Mar 2003 | - | $5.03B(-11.0%) |
| Dec 2002 | $20.07B(+9.0%) | $5.65B(+14.6%) |
| Sep 2002 | - | $4.93B(+2.3%) |
| Jun 2002 | - | $4.82B(+3.2%) |
| Mar 2002 | - | $4.67B(+30.6%) |
| Dec 2001 | $18.41B(-11.4%) | $3.58B(-28.3%) |
| Sep 2001 | - | $4.99B(-2.3%) |
| Jun 2001 | - | $5.10B(+5.0%) |
| Mar 2001 | - | $4.86B(-14.7%) |
| Dec 2000 | $20.79B(+1.8%) | $5.70B(+15.8%) |
| Sep 2000 | - | $4.92B(-3.8%) |
| Jun 2000 | - | $5.12B(+1.2%) |
| Mar 2000 | - | $5.05B(-10.1%) |
| Dec 1999 | $20.41B(+14.2%) | $5.62B(+8.6%) |
| Sep 1999 | - | $5.17B(+8.1%) |
| Jun 1999 | - | $4.79B(+72.8%) |
| Mar 1999 | - | $2.77B(-74.8%) |
| Dec 1998 | $17.88B(+124.0%) | $11.01B(+369.1%) |
| Sep 1998 | - | $2.35B(-2.2%) |
| Jun 1998 | - | $2.40B(+13.1%) |
| Mar 1998 | - | $2.12B(-9.0%) |
| Dec 1997 | $7.98B(+12.1%) | $2.33B(+21.5%) |
| Sep 1997 | - | $1.92B(-13.3%) |
| Jun 1997 | - | $2.22B(+6.9%) |
| Mar 1997 | - | $2.07B(+65.2%) |
| Dec 1996 | $7.12B(-4.6%) | $1.25B(-36.3%) |
| Sep 1996 | - | $1.97B(-5.7%) |
| Jun 1996 | - | $2.09B(+11.4%) |
| Mar 1996 | - | $1.87B(-9.5%) |
| Dec 1995 | $7.46B(+18.3%) | $2.07B(+12.1%) |
| Sep 1995 | - | $1.85B(-5.1%) |
| Jun 1995 | - | $1.95B(+9.8%) |
| Mar 1995 | - | $1.77B(-1.4%) |
| Dec 1994 | $6.31B(-3.9%) | $1.80B(+14.6%) |
| Sep 1994 | - | $1.57B(+2.7%) |
| Jun 1994 | - | $1.53B(+7.7%) |
| Mar 1994 | - | $1.42B(-39.3%) |
| Dec 1993 | $6.56B(+13.4%) | $2.33B(+63.9%) |
| Sep 1993 | - | $1.42B(+19.2%) |
| Jun 1993 | - | $1.20B(-13.4%) |
| Mar 1993 | - | $1.38B(-13.2%) |
| Dec 1992 | $5.79B(+1.6%) | $1.59B(+11.6%) |
| Sep 1992 | - | $1.42B(+0.3%) |
| Jun 1992 | - | $1.42B(+5.0%) |
| Mar 1992 | - | $1.35B(-14.9%) |
| Dec 1991 | $5.70B(+6.4%) | $1.59B(+13.6%) |
| Sep 1991 | - | $1.40B(+1.1%) |
| Jun 1991 | - | $1.38B(+4.6%) |
| Mar 1991 | - | $1.32B(-16.0%) |
| Dec 1990 | $5.35B(+13.8%) | $1.57B(+19.8%) |
| Sep 1990 | - | $1.31B(+2.2%) |
| Jun 1990 | - | $1.29B(+9.3%) |
| Mar 1990 | - | $1.18B |
| Dec 1989 | $4.70B(+7.5%) | - |
| Dec 1988 | $4.37B(+9.9%) | - |
| Dec 1987 | $3.98B(+13.2%) | - |
| Dec 1986 | $3.52B(+11.8%) | - |
| Dec 1985 | $3.14B(+4.1%) | - |
| Dec 1984 | $3.02B | - |
FAQ
- What is Pfizer annual total expenses?
- What is the all time high annual total expenses for Pfizer?
- What is Pfizer annual total expenses year-on-year change?
- What is Pfizer quarterly total expenses?
- What is the all time high quarterly total expenses for Pfizer?
- What is Pfizer quarterly total expenses year-on-year change?
What is Pfizer annual total expenses?
The current annual total expenses of PFE is $48.69B
What is the all time high annual total expenses for Pfizer?
Pfizer all-time high annual total expenses is $63.06B
What is Pfizer annual total expenses year-on-year change?
Over the past year, PFE annual total expenses has changed by -$6.45B (-11.69%)
What is Pfizer quarterly total expenses?
The current quarterly total expenses of PFE is $9.29B
What is the all time high quarterly total expenses for Pfizer?
Pfizer all-time high quarterly total expenses is $19.04B
What is Pfizer quarterly total expenses year-on-year change?
Over the past year, PFE quarterly total expenses has changed by -$1.39B (-12.97%)